Drug Interaction Concerns May Negatively Affect HIV Treatment Adherence Among Transgender Women

Medications, News & Updates, Patient Populations |

Source: hiv.gov

Participants in NIH-Supported Study Apprehensive about Combining HIV Medications and Hormones

Transgender women—people whose birth certificates indicate or once indicated male sex but who identify as women—are at high risk of HIV acquisition, and thus are a key population for HIV prevention and treatment efforts. A new study by researchers supported by the National Institutes of Health and Gilead Sciences reveals that among transgender women in Los Angeles, more than half of those living with HIV were concerned that taking both antiretroviral therapy (ART) for the treatment of HIV and feminizing hormone therapy (HT) may be associated with harmful drug interactions, about which little is clinically understood. Many in the surveyed group cited these concerns as a reason for not taking anti-HIV medications, HT, or both as prescribed by a health care professional.

Click Here To Read More